| Home | Bolesti | Dijagnostika | Lijekovi | Radovi | Novosti | Forum | Linkovi |
luk
Second Congress of Cardiology and Angiology of Bosnia & Herzegovina

 

REDUCTIVE ANNULOPLASTY OF DOUBLE MITRAL AND TRICUSPID ORIFICE FOR END-STAGE PRIMARY DILATED CARDIOMYOPATHY
N. Radovanović, Lj. Petrović, M. Zorc1, B. Mihajlović, M. Kovač, S. Ničin, M. Popov, V. Torbica and D. Uščumlić-Kovačević
University Clinic of Cardiovascular Surgery, Novi Sad, Yugoslavia, Institute of Histology, Medical Faculty1, Ljubljana, Slovenia

Background: Mitral and tricuspid regurgitation are unavoidable complications of the end-stage primary dilated cardiomyopathy (PDCM) significantly contributing to cardiac failure and predicting early lethal outcome. Medical treatment of these patients is not successful. Methods: This study shows long-term results in 80 pts (61 males, 19 females), mean age 49,9 years, operated due to end-stage PDCM. In all patients Reductive Annuloplasty of Double (mitral and tricuspid) Orifice (RADO) was done. In 9 and 71 cases, respectively, Carpentier's or our own procedures of mitral annuloplasty were performed, while tricuspid annuloplasty was done using our modification of De Vega's procedure. Results: Postoperative mortality-30 days was 1,2% (1/80). Cumulative survival at 5 years was 44,0±6,71% and fell to 26,6±10,2% at 9 years. Survival at 5 and 9 years according to preoperative ejection fraction (EF): Conclusion: After the results obtained by RADO for end-stage PCDM a significant hemodynamic and clinical improvement was observed. The follow -up study shows encouraging results, especially higher survival rate in the patients with EF higher than 20%. For this reason we propose RADO early after the first decompensation. .

Drugi kongres kardiologa i angiologa Bosne i Hercegovine
HealthBosnia.com - ima autorska prava na ovu stranu. Svako objavljivanje
teksta ili dijelova ovog teksta je moguće samo uz saglasnost HealthBosnia.com
© 1999-2001, by HealthBosnia.com, e-mail medmaster@koming.com. ALL RIGHTS RESERVED.